Hyperthyroidism is the most common endocrine disease in older cats. Multiple treatment options offer varying welfare profiles, and choosing the right approach significantly affects quality of life.
Hyperthyroidism causes genuine welfare compromise — the hypermetabolic state drives weight loss despite ravenous appetite, creating a state of metabolic hunger despite constant eating. Cardiac effects include hypertrophic cardiomyopathy and hypertension. Behavioural changes including hyperactivity and vocalisation reflect physiological disturbance. Effective treatment dramatically improves quality of life. Radioactive iodine provides a curative outcome with a single treatment and minimal ongoing stress. The key welfare consideration is treatment selection based on individual cat circumstances — some cats cannot travel for I-131 treatment, making daily medication the practical choice, with welfare monitoring for side effects. Masking of concurrent kidney disease requires careful monitoring during treatment transition.